Clinical relevance of Neutral Endopeptidase (NEP/CD10) in melanoma

Journal of Translational Medicine

Volumn 5, Issue , 2007, Pages

  Velazquez, Elsa F ^a,c   Yancovitz, Molly ^a   Pavlick, Anna ^a   Berman, Russell ^a   Shapiro, Richard ^a   Bogunovic, Dusan ^a   O'Neill, David ^a   Yu, Yi Lo ^a   Spira, Joanna ^a   Christos, Paul J ^b   Zhou, Xi Kathy ^b   Mazumdar, Madhu ^b   Nanus, David M ^b   Liebes, Leonard ^a   Bhardwaj, Nina ^a   Polsky, David ^a   Osman, Iman ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; DENDRITIC CELL VACCINE; DOUBLE STRANDED RNA; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12P70; MANNOSE RECEPTOR; POLYINOSINIC POLYCYTIDYLIC ACID; RESIQUIMOD; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TUMOR NECROSIS FACTOR ALPHA; MEMBRANE METALLOENDOPEPTIDASE; MESSENGER RNA;

ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; ARTICLE; CANCER PATIENT; CELL ACTIVATION; CELL MATURATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DRUG TARGETING; HELPER CELL; HUMAN; HUMAN CELL; IMMUNOMODULATION; TH1 CELL; BIOASSAY; DOWN REGULATION; ENZYMOLOGY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; IMMUNOHISTOCHEMISTRY; MELANOMA; METABOLISM; METASTASIS; SURVIVAL; TUMOR CELL LINE; TUMOR GENE;

CELL LINE, TUMOR; DOWN-REGULATION; ENDPOINT DETERMINATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, NEOPLASM; HUMANS; IMMUNOHISTOCHEMISTRY; MELANOMA; NEOPLASM METASTASIS; NEPRILYSIN; RNA, MESSENGER; SURVIVAL ANALYSIS;

EID: 33846661807     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-5-2     Document Type: Article

References (35)

1. Day AL Wick E Jordan TH Jaffray CE Bunnett NW Grady EF Kirkwood KS Neutral endopeptidase determines the severity of pancreatitis-associated lung injury J Surg Res 2005 128 1 21-27 15993898
2. Mellin V Jeng AY Monteil C Renet S Henry JP Thuillez C Mulder P Triple ACE-ECE-NEP inhibition in heart failure: A comparison with ACE and dual ECE-NEP inhibition J Cardiovasc Pharmacol 2005 46 3 390-397 10.1097/ 01.fjc.0000175457.48031.8b 16116347
3. Packer M Califf RM Konstam MA Krum H McMurray JJ Rouleau JL Swedberg K Comparison of omapatrilat and enalapril in patients with chronic heart failure: The Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE) Circulation 2002 106 8 920-926 10.1161/ 01.CIR.0000029801.86489.50 12186794
4. Sumitomo M Iwase A Zheng R Navarro D Kaminetzky D Shen R Georgescu MM Nanus DM Synergy in tumor suppression by direct interaction of neutral endopeptidase with PTEN Cancer Cell 2004 5 1 67-78 10.1016/ S1535-6108(03)00331-3 14749127
5. Cohen AJ Bunn PA Franklin W Magill-Solc C Hartmann C Helfrich B Gilman L Folkvord J Helm K Miller YE Neutral endopeptidase: Variable expression in human lung, inactivation in lung cancer, and modulation of peptide-induced calcium flux Cancer Res 1996 56 4 831-839 8631021
6. Osman I Yee H Taneja SS Levinson B Zeleniuch-Jacquotte A Chang C Nobert C Nanus DM Neutral endopeptidase protein expression and prognosis in localized prostate cancer Clin Cancer Res 2004 10 12 Pt 1 4096-4100 10.1158/1078-0432.CCR-04-0120 15217945
7. Fujimoto Y Nakanishi Y Sekine S Yoshimura K Akasu T Moriya Y Shimoda T CD10 expression in colorectal carcinoma correlates with liver metastasis Dis Colon Rectum 2005 48 10 1883-1889 10.1007/s10350-005-0141-6 16175325
8. Bai M Agnantis NJ Skyrlas A Tsanou E Kamina S Galani V Kanavaros P Increased expression of the bcl6 and CD10 proteins is associated with increased apoptosis and proliferation in diffuse large B-cell lymphomas Mod Pathol 2003 16 5 471-480 10.1097/01.MP.0000067684.78221.6E 12748254
9. Sumitomo M Milowsky MI Shen R Navarro D Dai J Asano T Hayakawa M Nanus DM Neutral endopeptidase inhibits neuropeptide-mediated transactivation of the insulin-like growth factor receptor-Akt cell survival pathway Cancer Res 2001 61 8 3294-3298 11309283
10. Iwase T Kushima R Mukaisho K Mitsufuji S Okanoue T Hattori T Overexpression of CD10 and reduced MUC2 expression correlate with the development and progression of colorectal neoplasms Pathol Res Pract 2005 201 2 83-91 10.1016/j.prp.2004.09.016 15901128
11. Huang WB Zhou XJ Chen JY Zhang LH Meng K Ma HH Lu ZF CD10-positive stromal cells in gastric carcinoma: Correlation with invasion and metastasis Jpn J Clin Oncol 2005 35 5 245-250 10.1093/jjco/hyi076 15886270
12. Iwaya K Ogawa H Izumi M Kuroda M Mukai K Stromal expression of CD10 in invasive breast carcinoma: A new predictor of clinical outcome Virchows Arch 2002 440 6 589-593 10.1007/s00428-002-0639-4 12070597
13. Ogawa H Iwaya K Izumi M Kuroda M Serizawa H Koyanagi Y Mukai K Expression of CD10 by stromal cells during colorectal tumor development Hum Pathol 2002 33 8 806-811 10.1053/hupa.2002.125773 12203213
14. Cruden NL Fox KA Ludlam CA Johnston NR Newby DE Neutral endopeptidase inhibition augments vascular actions of bradykinin in patients treated with angiotensin-converting enzyme inhibition Hypertension 2004 44 6 913-918 10.1161/01.HYP.0000146483.78994.56 15492133
15. de Gouw HW Diamant Z Kuijpers EA Sont JK Sterk PJ Role of neutral endopeptidase in exercise-induced bronchoconstriction in asthmatic subjects J Appl Physiol 1996 81 2 673-678 8872633
16. The Bioconductor project http://www.bioconductor.org [Accessed November 16, 2006]
17. The R project for Statistical Computing http://www.r-project.org/ [Accessed November 16, 2006]
18. Irizarry RA Hobbs B Collin F Beazer-Barclay YD Antonellis KJ Scherf U Speed TP Exploration, normalization, and summaries of high density oligonucleotide array probe level data Biostatistics 2003 4 2 249-264 10.1093/biostatistics/4.2.249 12925520
19. Talantov D Mazumder A Yu JX Briggs T Jiang Y Backus J Atkins D Wang Y Novel genes associated with malignant melanoma but not benign melanocytic lesions Clin Cancer Res 2005 11 20 7234-7242 10.1158/ 1078-0432.CCR-05-0683 16243793
20. Osman I Yee H Taneja S Levinson B Zeleniuch-Jacquotte A Chang C Norbert C Nanus DM Neutral Endopeptidase 24.11 loss in metastatic human prostate cancer contributes to androgen-independent progression Nat Med 1998 4 50-57 10.1038/nm0198-050 9427606
21. Curtin JA Fridlyand J Kageshita T Patel HN Busam KJ Kutzner H Cho KH Aiba S Brocker EB LeBoit PE Pinkel D Bastian BC Distinct sets of genetic alterations in melanoma N Engl J Med 2005 353 20 2135-2147 10.1056/ NEJMoa050092 16291983
22. Bilalovic N Sandstad B Golouh R Nesland JM Selak I Torlakovic EE CD10 protein expression in tumor and stromal cells of malignant melanoma is associated with tumor progression Mod Pathol 2004 17 10 1251-1258 10.1038/modpathol.3800174 15205682
23. Kanitakis J Narvaez D Claudy A Differential expression of the CD10 antigen (neutral endopeptidase) in primary versus metastatic malignant melanomas of the skin Melanoma Res 2002 12 3 241-244 10.1097/ 00008390-200206000-00007 12140380
24. Schaffer JV Rigel DS Kopf AW Bolognia JL Cutaneous melanoma - past, present, and future J Am Acad Dermatol 2004 51 1 Suppl S65-9 10.1016/ j.jaad.2004.01.030 15243517
25. Bizari L Borim AA Moreira Leite KR de Toledo Goncalves F Cury PM Tajara EH Silva AE Alterations of the CCND1 and HER-2/neu (ERBB2) proteins in esophageal and gastric cancers Cancer Genet Cytogenet 2006 165 1 41-50 10.1016/j.cancergencyto.2005.08.031 16490596
26. Sunpaweravong P Sunpaweravong S Puttawibul P Mitarnun W Zeng C Baron AE Franklin W Said S Varella-Garcia M Epidermal growth factor receptor and cyclin D1 are independently amplified and overexpressed in esophageal squamous cell carcinoma J Cancer Res Clin Oncol 2005 131 2 111-119 10.1007/s00432-004-0610-7 15672286
27. Hirsch FR Varella-Garcia M Bunn PA Jr. Di Maria MV Veve R Bremmes RM Baron AE Zeng C Franklin WA Epidermal growth factor receptor in non-small-cell lung carcinomas: Correlation between gene copy number and protein expression and impact on prognosis J Clin Oncol 2003 21 20 3798-3807 10.1200/JCO.2003.11.069 12953099
28. Depeille P Cuq P Passagne I Evrard A Vian L Combined effects of GSTP1 and MRP1 in melanoma drug resistance Br J Cancer 2005 93 2 216-223 10.1038/sj.bjc.6602681 15999103
29. Shao GZ Zhou RL Zhang QY Zhang Y Liu JJ Rui JA Wei X Ye DX Molecular cloning and characterization of LAPTM4B, a novel gene upregulated in hepatocellular carcinoma Oncogene 2003 22 32 5060-5069 10.1038/ sj.onc.1206832 12902989
30. Kasper G Vogel A Klaman I Grone J Petersen I Weber B Castanos-Velez E Staub E Mennerich D The human LAPTM4b transcript is upregulated in various types of solid tumours and seems to play a dual functional role during tumour progression Cancer Lett 2005 224 1 93-103 15911104
31. Oka M Kikkawa U Protein kinase C in melanoma Cancer Metastasis Rev 2005 24 2 287-300 10.1007/s10555-005-1578-8 15986138
32. Selzer E Okamoto I Lucas T Kodym R Pehamberger H Jansen B Protein kinase C isoforms in normal and transformed cells of the melanocytic lineage Melanoma Res 2002 12 3 201-209 10.1097/00008390-200206000-00003 12140376
33. Thiebault K Mazelin L Pays L Llambi F Joly MO Scoazec JY Saurin JC Romeo G Mehlen P The netrin-1 receptors UNC5H are putative tumor suppressors controlling cell death commitment Proc Natl Acad Sci U S A 2003 100 7 4173-4178 153067 12655055 10.1073/pnas.0738063100
34. Tanikawa C Matsuda K Fukuda S Nakamura Y Arakawa H p53RDL1 regulates p53-dependent apoptosis Nat Cell Biol 2003 5 3 216-223 10.1038/ncb943 12598906
35. Sagara Y Mimori K Yoshinaga K Tanaka F Nishida K Ohno S Inoue H Mori M Clinical significance of Caveolin-1, Caveolin-2 and HER2/neu mRNA expression in human breast cancer Br J Cancer 2004 91 5 959-965 15305200